Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B.
It was known for six major products, including Lovaza (Omega-3), Axid (H2 blocker), Dynacirc CR (calcium channel blocker), Antara (fenofibrate), InnoPran XL (beta blocker), Lescol XL (Fluvastatin), and Rythmol SR (Class IC anti-arrhythmic).
Reliant marketed six cardiovascular products in the United States and focused on promoting its products to targeted primary care and specialty physicians, as well as selected hospitals and academic centers in the United States.
[2] The Lovaza drug accounted for 60% of the sales of the company for that period.
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.